1-2 of 2
Claas Reimer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD127-Directed Immunotherapy with Lusvertikimab Outperforms Imatinib in Preclinical ABL-Class-Fusion-Positive BCP-ALL

Anna Dietterle, Julia Heymann, Anna Laqua, Claas Reimer, Denny Takudzwa Mahachi, Carina Lynn Gehlert, Dorothee Winterberg, Maja Kowol, Alexander Arthur Wurm, Philipp Fanter, Denis Pinkle, Dennis Das Gupta, Christian Vokuhl, Jan Philipp Schmid, Matthias Peipp, Martin Schrappe, Irène Baccelli, Nicolas Poirier, Monika Brüggemann, Gunnar Cario, Denis Martin Schewe, Lennart Lenk
Journal: Blood
Blood (2024) 144 (Supplement 1): 636.
https://doi.org/10.1182/blood-2024-205421
Published: 2024
Journal Articles

The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis

Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L. den Boer, Judith M. Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke K. Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis M. Schewe
Journal: Blood
Blood (2024) 143 (26): 2735–2748.
https://doi.org/10.1182/blood.2023021088
Published: 2024
Includes: Supplemental data